[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1984

Pediatric Pemphigus VulgarisTreatment With Topical Adrenal Steroids

Author Affiliations

USAF

From the Department of Dermatology, Wilford Hall USAF Medical Center, San Antonio, Tex (Dr Hempstead), and the Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey (Dr Marks).

Arch Dermatol. 1984;120(7):962-963. doi:10.1001/archderm.1984.01650430152029
Abstract

Pemphigus is an autoimmune blistering disease affecting the skin and mucous membranes. It is most commonly seen in middle to old age, with a mean age of onset in the sixth decade. With the exception of an anecdotal report from Budapest,1 claiming a high incidence of pemphigus vulgaris in children, most authors have pointed out that all forms of pemphigus rarely occur in childhood and adolescence.2-4

We describe a 13-year-old girl with pemphigus vulgaris confined to the mouth. She was treated only with topical corticosteroids. High-dose corticosteroid therapy with or without immunosuppressive agents may not be necessary in all cases of pediatric pemphigus vulgaris.

Report of a Case  A 13-year-old girl was seen in the dermatology clinic with a two-year history of painful, eroded gingival, lingual, and buccal mucosal lesions. Several dentists had remarked about the friability of her gums; however, dental braces had been fitted uneventfully. She

First Page Preview View Large
First page PDF preview
First page PDF preview
×